China Medical System Holdings Ltd
HKEX:867
Intrinsic Value
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. [ Read More ]
The intrinsic value of one China Medical System Holdings Ltd stock under the Base Case scenario is 17.78 HKD. Compared to the current market price of 7.1 HKD, China Medical System Holdings Ltd is Undervalued by 60%.
Valuation Backtest
China Medical System Holdings Ltd
Run backtest to discover the historical profit from buying and selling China Medical System Holdings Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
China Medical System Holdings Ltd
| Current Assets | 8.8B |
| Cash & Short-Term Investments | 6.1B |
| Receivables | 2B |
| Other Current Assets | 637.6m |
| Non-Current Assets | 8.9B |
| Long-Term Investments | 3.6B |
| PP&E | 1.5B |
| Intangibles | 3.8B |
| Other Non-Current Assets | 70.4m |
| Current Liabilities | 2B |
| Accounts Payable | 437m |
| Other Current Liabilities | 1.6B |
| Non-Current Liabilities | 161.8m |
| Long-Term Debt | 16.7m |
| Other Non-Current Liabilities | 145.2m |
Earnings Waterfall
China Medical System Holdings Ltd
|
Revenue
|
8B
CNY
|
|
Cost of Revenue
|
-1.9B
CNY
|
|
Gross Profit
|
6.1B
CNY
|
|
Operating Expenses
|
-3.2B
CNY
|
|
Operating Income
|
2.9B
CNY
|
|
Other Expenses
|
-523.5m
CNY
|
|
Net Income
|
2.4B
CNY
|
Free Cash Flow Analysis
China Medical System Holdings Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
China Medical System Holdings Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Score
China Medical System Holdings Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Medical System Holdings Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
China Medical System Holdings Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China Medical System Holdings Ltd
According to Wall Street analysts, the average 1-year price target for China Medical System Holdings Ltd is 18.66 HKD with a low forecast of 17.75 HKD and a high forecast of 19.95 HKD.
Shareholder Return
Price
China Medical System Holdings Ltd
| Average Annual Return | 25.11% |
| Standard Deviation of Annual Returns | 40.23% |
| Max Drawdown | -65% |
| Market Capitalization | 17.3B HKD |
| Shares Outstanding | 2 451 990 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company is headquartered in Shenzhen, Guangdong and currently employs 5,292 full-time employees. The company went IPO on 2010-09-28. Its main products under direct network include Deanxit, Ursofalk, XinHuoSu, Salofalk, Bioflor and Augentropfen Stulln Mono Eye-drops, among others. Its products under the agency promotion network include ShaDuoLiKa, YiNuoShu and XiDaKang, among others. The products of the Company are used in the treatment of gastropathy, cardiopathy, traumatic infection, hepatopathy and eye diseases, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one China Medical System Holdings Ltd stock under the Base Case scenario is 17.78 HKD.
Compared to the current market price of 7.1 HKD, China Medical System Holdings Ltd is Undervalued by 60%.
You don't have any saved screeners yet
